# SailPoint, Inc.: financial statements, quarterly

SAIL · Nasdaq · CIK 2030781 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/sail.md) · [Financials](/companies/sail/financials.md) · [Filings](/companies/sail/filings.md) · [Insiders](/companies/sail/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sail/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2024-04-30) | period not labelled (2024-07-31) | period not labelled (2024-10-31) | period not labelled (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [188](/filings/0002030781-25-000024.md) | [199](/filings/0002030781-25-000035.md) | [235](/filings/0002030781-25-000051.md) | [240 d](/filings/0002030781-26-000003.md) | [230](/filings/0002030781-26-000011.md) | [264](/filings/0002030781-26-000021.md) | [282](/filings/0002030781-25-000051.md) | [295 d](/filings/0002030781-26-000003.md) | [280](/filings/0002030781-26-000011.md) | [309](/filings/0002030781-26-000021.md) |
| Cost of revenue | $m | [72.2](/filings/0002030781-25-000024.md) | [75.3](/filings/0002030781-25-000035.md) | [78.0](/filings/0002030781-25-000051.md) | [80.3 d](/filings/0002030781-26-000003.md) | [103](/filings/0002030781-26-000011.md) | [86.6](/filings/0002030781-26-000021.md) | [94.9](/filings/0002030781-25-000051.md) | [96.4 d](/filings/0002030781-26-000003.md) | [99.0](/filings/0002030781-26-000011.md) | [103](/filings/0002030781-26-000021.md) |
| Gross profit | $m | [115](/filings/0002030781-25-000024.md) | [123](/filings/0002030781-25-000035.md) | [157](/filings/0002030781-25-000051.md) | [160 d](/filings/0002030781-26-000003.md) | [128](/filings/0002030781-26-000011.md) | [178](/filings/0002030781-26-000021.md) | [187](/filings/0002030781-25-000051.md) | [198 d](/filings/0002030781-26-000003.md) | [181](/filings/0002030781-26-000011.md) | [205](/filings/0002030781-26-000021.md) |
| Research and development | $m | [41.9](/filings/0002030781-25-000024.md) | [43.1](/filings/0002030781-25-000035.md) | [39.2](/filings/0002030781-25-000051.md) | [45.5 d](/filings/0002030781-26-000003.md) | [67.3](/filings/0002030781-26-000011.md) | [48.1](/filings/0002030781-26-000021.md) | [51.2](/filings/0002030781-25-000051.md) | [56.4 d](/filings/0002030781-26-000003.md) | [61.7](/filings/0002030781-26-000011.md) | [62.2](/filings/0002030781-26-000021.md) |
| Operating income | $m | [(68.2)](/filings/0002030781-25-000024.md) | [(65.8)](/filings/0002030781-25-000035.md) | [(24.5)](/filings/0002030781-25-000051.md) | [(30.2) d](/filings/0002030781-26-000003.md) | [(185)](/filings/0002030781-26-000011.md) | [(40.8)](/filings/0002030781-26-000021.md) | [(41.6)](/filings/0002030781-25-000051.md) | [(40.1) d](/filings/0002030781-26-000003.md) | [(79.8)](/filings/0002030781-26-000011.md) | [(59.0)](/filings/0002030781-26-000021.md) |
| Interest expense | $m | [46.2](/filings/0002030781-25-000024.md) | [47.3](/filings/0002030781-25-000035.md) | [46.6](/filings/0002030781-25-000051.md) | [46.5 d](/filings/0002030781-26-000003.md) | [22.4](/filings/0002030781-26-000011.md) | [1.7](/filings/0002030781-26-000021.md) | [0.3](/filings/0002030781-25-000051.md) | [0.3 d](/filings/0002030781-26-000003.md) | [0.3](/filings/0002030781-26-000011.md) | [0.3](/filings/0002030781-26-000021.md) |
| Income tax | $m | [(24.5)](/filings/0002030781-25-000024.md) | [(26.1)](/filings/0002030781-25-000035.md) | [(11.9)](/filings/0002030781-25-000051.md) | [1.7 d](/filings/0002030781-26-000003.md) | [(17.0)](/filings/0002030781-26-000011.md) | [(31.3)](/filings/0002030781-26-000021.md) | [(4.8)](/filings/0002030781-25-000051.md) | [(2.8) d](/filings/0002030781-26-000003.md) | [(5.4)](/filings/0002030781-26-000011.md) | [(6.8)](/filings/0002030781-26-000021.md) |
| Net income | $m | [(89.2)](/filings/0002030781-25-000024.md) | [(87.1)](/filings/0002030781-25-000035.md) | [(59.4)](/filings/0002030781-25-000051.md) | [(80.1) d](/filings/0002030781-26-000003.md) | [(187)](/filings/0002030781-26-000011.md) | [(10.6)](/filings/0002030781-26-000021.md) | [(36.0)](/filings/0002030781-25-000051.md) | [(36.2) d](/filings/0002030781-26-000003.md) | [(74.7)](/filings/0002030781-26-000011.md) | [(50.4)](/filings/0002030781-26-000021.md) |
| Diluted EPS | $ per share | [(0.77)](/filings/0002030781-25-000024.md) | [(2.97)](/filings/0002030781-25-000035.md) | [(2.67)](/filings/0002030781-25-000051.md) | not reported | [(0.42)](/filings/0002030781-26-000011.md) | [(0.02)](/filings/0002030781-26-000021.md) | [(0.06)](/filings/0002030781-25-000051.md) | not reported | [(0.13)](/filings/0002030781-26-000011.md) | [(0.09)](/filings/0002030781-26-000021.md) |
| Basic EPS | $ per share | [(0.77)](/filings/0002030781-25-000024.md) | [(2.97)](/filings/0002030781-25-000035.md) | [(2.67)](/filings/0002030781-25-000051.md) | not reported | [(0.42)](/filings/0002030781-26-000011.md) | [(0.02)](/filings/0002030781-26-000021.md) | [(0.06)](/filings/0002030781-25-000051.md) | not reported | [(0.13)](/filings/0002030781-26-000011.md) | [(0.09)](/filings/0002030781-26-000021.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2023-01-31) | period not labelled (2024-01-31) | period not labelled (2024-04-30) | period not labelled (2024-07-31) | period not labelled (2024-10-31) | period not labelled (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | [212](/filings/0002030781-26-000003.md) | [147](/filings/0002030781-25-000024.md) | [89.7](/filings/0002030781-25-000035.md) | [68.2](/filings/0002030781-25-000051.md) | [121](/filings/0002030781-26-000003.md) | [228](/filings/0002030781-26-000011.md) | [271](/filings/0002030781-26-000021.md) | [298](/filings/0002030781-25-000051.md) | [358](/filings/0002030781-26-000021.md) | [391](/filings/0002030781-26-000011.md) | [310](/filings/0002030781-26-000021.md) |
| Current assets | $m | not reported | not reported | not reported | not reported | not reported | [512](/filings/0002030781-26-000003.md) | [557](/filings/0002030781-25-000024.md) | [627](/filings/0002030781-25-000035.md) | [670](/filings/0002030781-25-000051.md) | [851](/filings/0002030781-26-000021.md) | [823](/filings/0002030781-26-000011.md) | [777](/filings/0002030781-26-000021.md) |
| Total assets | $m | not reported | not reported | not reported | not reported | not reported | [7,412](/filings/0002030781-26-000003.md) | [7,414](/filings/0002030781-25-000024.md) | [7,446](/filings/0002030781-25-000035.md) | [7,475](/filings/0002030781-25-000051.md) | [7,598](/filings/0002030781-26-000021.md) | [7,526](/filings/0002030781-26-000011.md) | [7,584](/filings/0002030781-26-000021.md) |
| Current liabilities | $m | not reported | not reported | not reported | not reported | not reported | [575](/filings/0002030781-26-000003.md) | [475](/filings/0002030781-25-000024.md) | [504](/filings/0002030781-25-000035.md) | [525](/filings/0002030781-25-000051.md) | [643](/filings/0002030781-26-000021.md) | [590](/filings/0002030781-26-000011.md) | [633](/filings/0002030781-26-000021.md) |
| Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | [1,804](/filings/0002030781-26-000003.md) | [637](/filings/0002030781-25-000024.md) | [630](/filings/0002030781-25-000035.md) | [645](/filings/0002030781-25-000051.md) | [751](/filings/0002030781-26-000021.md) | [684](/filings/0002030781-26-000011.md) | [722](/filings/0002030781-26-000021.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [1,024](/filings/0002030781-26-000003.md) | [0.0](/filings/0002030781-25-000024.md) | [0.0](/filings/0002030781-25-000035.md) | [0.0](/filings/0002030781-25-000051.md) | [0.0](/filings/0002030781-26-000003.md) | not reported | not reported |
| Shareholders' equity | $m | [(183)](/filings/0002030781-26-000003.md) | [(541)](/filings/0002030781-26-000003.md) | [(623)](/filings/0002030781-25-000035.md) | [(701)](/filings/0002030781-25-000051.md) | [(754)](/filings/0002030781-25-000051.md) | [(5,588)](/filings/0002030781-26-000021.md) | [6,778](/filings/0002030781-26-000021.md) | [6,816](/filings/0002030781-26-000021.md) | [6,830](/filings/0002030781-25-000051.md) | [6,846](/filings/0002030781-26-000021.md) | [6,842](/filings/0002030781-26-000021.md) | [6,862](/filings/0002030781-26-000021.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | period not labelled (2024-04-30) | period not labelled (2024-07-31) | period not labelled (2024-10-31) | period not labelled (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(55.4)](/filings/0002030781-25-000024.md) | [(52.8) d](/filings/0002030781-25-000035.md) | [(12.0) d](/filings/0002030781-25-000051.md) | [13.8 d](/filings/0002030781-26-000003.md) | [(96.8)](/filings/0002030781-26-000011.md) | [49.9 d](/filings/0002030781-26-000021.md) | [53.6 d](/filings/0002030781-25-000051.md) | [63.9 d](/filings/0002030781-26-000003.md) | [38.2](/filings/0002030781-26-000011.md) | [45.0 d](/filings/0002030781-26-000021.md) |
| Capital expenditure | $m | [0.6](/filings/0002030781-25-000024.md) | [0.9 d](/filings/0002030781-25-000035.md) | [2.3 d](/filings/0002030781-25-000051.md) | [1.5 d](/filings/0002030781-26-000003.md) | [2.2](/filings/0002030781-26-000011.md) | [1.0 d](/filings/0002030781-26-000021.md) | [1.0 d](/filings/0002030781-25-000051.md) | [1.8 d](/filings/0002030781-26-000003.md) | [1.0](/filings/0002030781-26-000011.md) | [1.9 d](/filings/0002030781-26-000021.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2024-04-30) | period not labelled (2024-07-31) | period not labelled (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [182](/filings/0002030781-25-000024.md) | [82.7](/filings/0002030781-25-000035.md) | [82.9](/filings/0002030781-25-000051.md) | [500](/filings/0002030781-26-000011.md) | [556](/filings/0002030781-26-000021.md) | [558](/filings/0002030781-25-000051.md) | [565](/filings/0002030781-26-000011.md) | [568](/filings/0002030781-26-000021.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 570,911,633 at 2026-09-04, from the cover of the [10-Q filed 2026-09-10](/filings/0002030781-26-000021.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.
